Review





Similar Products

98
Proteintech sa00001 2 rrid ab 2722564 biological samples human postmortem brain tissue fudan brain bank ethics 2019c025 chemicals
Sa00001 2 Rrid Ab 2722564 Biological Samples Human Postmortem Brain Tissue Fudan Brain Bank Ethics 2019c025 Chemicals, supplied by Proteintech, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sa00001 2 rrid ab 2722564 biological samples human postmortem brain tissue fudan brain bank ethics 2019c025 chemicals/product/Proteintech
Average 98 stars, based on 1 article reviews
sa00001 2 rrid ab 2722564 biological samples human postmortem brain tissue fudan brain bank ethics 2019c025 chemicals - by Bioz Stars, 2026-04
98/100 stars
  Buy from Supplier

90
Hamamatsu postmortem brain tissue specimens
Postmortem Brain Tissue Specimens, supplied by Hamamatsu, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/postmortem brain tissue specimens/product/Hamamatsu
Average 90 stars, based on 1 article reviews
postmortem brain tissue specimens - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Partners HealthCare System Inc canvas and control postmortem brain tissue
( A ) Schematic of <t>brain,</t> central and peripheral nervous system regions affected in CANVAS (left), and potential mechanisms of repeat toxicity in CANVAS (right). ( B ) Repeat architecture of the expanded locus and CRISPR gRNA design to remove the AAGGG/CCCTT repeat expansion by nonhomologous end joining (NHEJ). ( C ) Endpoint PCR of gDNA extracted from CANVAS patient– and <t>control-derived</t> iPSC lines and CANVAS and control cerebellum <t>tissue</t> utilizing the primer pair outlined in (B) to screen for the presence of WT repeat, mutant repeat expansion, or deletion of expanded repeat. ( D ) Chromatogram of Sanger sequencing identifying AAGGG/CCCTT allele deletion in heterozygous isogenic line indicating the expected NHEJ join point compared to the control iPSC line. ( E ) Schematic outlining the repeat copy number per allele for each of the patient-derived iPSC lines used as identified by Oxford Nanopore gDNA targeted long-read sequencing. Green, sub-pathogenic repeat length; Red, pathogenic repeat length. Error bars indicate confidence in exact copy number calls. The “*” indicates lower boundary for repeat copy number from the longest read observed due to the absence of reads spanning the full repeat.
Canvas And Control Postmortem Brain Tissue, supplied by Partners HealthCare System Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/canvas and control postmortem brain tissue/product/Partners HealthCare System Inc
Average 90 stars, based on 1 article reviews
canvas and control postmortem brain tissue - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare postmortem brain tissues
( A ) Schematic of <t>brain,</t> central and peripheral nervous system regions affected in CANVAS (left), and potential mechanisms of repeat toxicity in CANVAS (right). ( B ) Repeat architecture of the expanded locus and CRISPR gRNA design to remove the AAGGG/CCCTT repeat expansion by nonhomologous end joining (NHEJ). ( C ) Endpoint PCR of gDNA extracted from CANVAS patient– and <t>control-derived</t> iPSC lines and CANVAS and control cerebellum <t>tissue</t> utilizing the primer pair outlined in (B) to screen for the presence of WT repeat, mutant repeat expansion, or deletion of expanded repeat. ( D ) Chromatogram of Sanger sequencing identifying AAGGG/CCCTT allele deletion in heterozygous isogenic line indicating the expected NHEJ join point compared to the control iPSC line. ( E ) Schematic outlining the repeat copy number per allele for each of the patient-derived iPSC lines used as identified by Oxford Nanopore gDNA targeted long-read sequencing. Green, sub-pathogenic repeat length; Red, pathogenic repeat length. Error bars indicate confidence in exact copy number calls. The “*” indicates lower boundary for repeat copy number from the longest read observed due to the absence of reads spanning the full repeat.
Postmortem Brain Tissues, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/postmortem brain tissues/product/Johns Hopkins HealthCare
Average 90 stars, based on 1 article reviews
postmortem brain tissues - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare postmortem als brain tissue from motor and occipital cortex
( A ) Schematic of <t>brain,</t> central and peripheral nervous system regions affected in CANVAS (left), and potential mechanisms of repeat toxicity in CANVAS (right). ( B ) Repeat architecture of the expanded locus and CRISPR gRNA design to remove the AAGGG/CCCTT repeat expansion by nonhomologous end joining (NHEJ). ( C ) Endpoint PCR of gDNA extracted from CANVAS patient– and <t>control-derived</t> iPSC lines and CANVAS and control cerebellum <t>tissue</t> utilizing the primer pair outlined in (B) to screen for the presence of WT repeat, mutant repeat expansion, or deletion of expanded repeat. ( D ) Chromatogram of Sanger sequencing identifying AAGGG/CCCTT allele deletion in heterozygous isogenic line indicating the expected NHEJ join point compared to the control iPSC line. ( E ) Schematic outlining the repeat copy number per allele for each of the patient-derived iPSC lines used as identified by Oxford Nanopore gDNA targeted long-read sequencing. Green, sub-pathogenic repeat length; Red, pathogenic repeat length. Error bars indicate confidence in exact copy number calls. The “*” indicates lower boundary for repeat copy number from the longest read observed due to the absence of reads spanning the full repeat.
Postmortem Als Brain Tissue From Motor And Occipital Cortex, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/postmortem als brain tissue from motor and occipital cortex/product/Johns Hopkins HealthCare
Average 90 stars, based on 1 article reviews
postmortem als brain tissue from motor and occipital cortex - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare formalin-fixed paraffin-embedded sections of human postmortem brain tissue
( A ) Schematic of <t>brain,</t> central and peripheral nervous system regions affected in CANVAS (left), and potential mechanisms of repeat toxicity in CANVAS (right). ( B ) Repeat architecture of the expanded locus and CRISPR gRNA design to remove the AAGGG/CCCTT repeat expansion by nonhomologous end joining (NHEJ). ( C ) Endpoint PCR of gDNA extracted from CANVAS patient– and <t>control-derived</t> iPSC lines and CANVAS and control cerebellum <t>tissue</t> utilizing the primer pair outlined in (B) to screen for the presence of WT repeat, mutant repeat expansion, or deletion of expanded repeat. ( D ) Chromatogram of Sanger sequencing identifying AAGGG/CCCTT allele deletion in heterozygous isogenic line indicating the expected NHEJ join point compared to the control iPSC line. ( E ) Schematic outlining the repeat copy number per allele for each of the patient-derived iPSC lines used as identified by Oxford Nanopore gDNA targeted long-read sequencing. Green, sub-pathogenic repeat length; Red, pathogenic repeat length. Error bars indicate confidence in exact copy number calls. The “*” indicates lower boundary for repeat copy number from the longest read observed due to the absence of reads spanning the full repeat.
Formalin Fixed Paraffin Embedded Sections Of Human Postmortem Brain Tissue, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/formalin-fixed paraffin-embedded sections of human postmortem brain tissue/product/Johns Hopkins HealthCare
Average 90 stars, based on 1 article reviews
formalin-fixed paraffin-embedded sections of human postmortem brain tissue - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare postmortem als brain tissue
(A and B) Immunohistochemistry of VCP and SOD1 in postmortem motor (affected) (A) and occipital (unaffected) (B) cortex from an <t>ALS</t> patient <t>(patient</t> <t>#1-JHU74)</t> carrying the A4V mutation in the SOD1 gene. The pictures on the right column represent the magnified regions within the yellow dashed squares. Scale bar, 20 μm. (C) Quantification of SOD1 and VCP intensities in MAP2 + neurons within the motor or occipital cortex. Motor cortex, n = 17 neurons; occipital cortex, n = 16 neurons. Unpaired t test (two-tailed), SOD1 p < 0.0001; VCP p < 0.0001.
Postmortem Als Brain Tissue, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/postmortem als brain tissue/product/Johns Hopkins HealthCare
Average 90 stars, based on 1 article reviews
postmortem als brain tissue - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare postmortem brain tissue
(A and B) Immunohistochemistry of VCP and SOD1 in postmortem motor (affected) (A) and occipital (unaffected) (B) cortex from an <t>ALS</t> patient <t>(patient</t> <t>#1-JHU74)</t> carrying the A4V mutation in the SOD1 gene. The pictures on the right column represent the magnified regions within the yellow dashed squares. Scale bar, 20 μm. (C) Quantification of SOD1 and VCP intensities in MAP2 + neurons within the motor or occipital cortex. Motor cortex, n = 17 neurons; occipital cortex, n = 16 neurons. Unpaired t test (two-tailed), SOD1 p < 0.0001; VCP p < 0.0001.
Postmortem Brain Tissue, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/postmortem brain tissue/product/Johns Hopkins HealthCare
Average 90 stars, based on 1 article reviews
postmortem brain tissue - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


( A ) Schematic of brain, central and peripheral nervous system regions affected in CANVAS (left), and potential mechanisms of repeat toxicity in CANVAS (right). ( B ) Repeat architecture of the expanded locus and CRISPR gRNA design to remove the AAGGG/CCCTT repeat expansion by nonhomologous end joining (NHEJ). ( C ) Endpoint PCR of gDNA extracted from CANVAS patient– and control-derived iPSC lines and CANVAS and control cerebellum tissue utilizing the primer pair outlined in (B) to screen for the presence of WT repeat, mutant repeat expansion, or deletion of expanded repeat. ( D ) Chromatogram of Sanger sequencing identifying AAGGG/CCCTT allele deletion in heterozygous isogenic line indicating the expected NHEJ join point compared to the control iPSC line. ( E ) Schematic outlining the repeat copy number per allele for each of the patient-derived iPSC lines used as identified by Oxford Nanopore gDNA targeted long-read sequencing. Green, sub-pathogenic repeat length; Red, pathogenic repeat length. Error bars indicate confidence in exact copy number calls. The “*” indicates lower boundary for repeat copy number from the longest read observed due to the absence of reads spanning the full repeat.

Journal: Science Advances

Article Title: AAGGG repeat expansions trigger RFC1 -independent synaptic dysregulation in human CANVAS neurons

doi: 10.1126/sciadv.adn2321

Figure Lengend Snippet: ( A ) Schematic of brain, central and peripheral nervous system regions affected in CANVAS (left), and potential mechanisms of repeat toxicity in CANVAS (right). ( B ) Repeat architecture of the expanded locus and CRISPR gRNA design to remove the AAGGG/CCCTT repeat expansion by nonhomologous end joining (NHEJ). ( C ) Endpoint PCR of gDNA extracted from CANVAS patient– and control-derived iPSC lines and CANVAS and control cerebellum tissue utilizing the primer pair outlined in (B) to screen for the presence of WT repeat, mutant repeat expansion, or deletion of expanded repeat. ( D ) Chromatogram of Sanger sequencing identifying AAGGG/CCCTT allele deletion in heterozygous isogenic line indicating the expected NHEJ join point compared to the control iPSC line. ( E ) Schematic outlining the repeat copy number per allele for each of the patient-derived iPSC lines used as identified by Oxford Nanopore gDNA targeted long-read sequencing. Green, sub-pathogenic repeat length; Red, pathogenic repeat length. Error bars indicate confidence in exact copy number calls. The “*” indicates lower boundary for repeat copy number from the longest read observed due to the absence of reads spanning the full repeat.

Article Snippet: CANVAS and control postmortem brain tissue was obtained with informed consent of the patients or their relatives and the approval of the local IRBs from the University of Michigan Brain Bank (IRB: HUM00041576), Mass General Brigham Stem Cells in Neurodegeneration Center (IRB: 2020P002649), UCL Queen Square Brain Bank for Neurological Disorders (REC: 08/H0718/54+5), and The Netherlands Brain Bank (IRB: IRB00002991).

Techniques: CRISPR, Control, Derivative Assay, Mutagenesis, Sequencing

( A ) Schematic of potential peptide products from sense and antisense strand of the repeat expansion locus. ( B ) Quantification of foci positive neurons for control ( n = 3) and CANVAS ( n = 3) patient iPSC-derived neurons (1100 to 2000 cells per group per probe). n = 2 biological replicates from three independent patient-derived cell lines. Representative confocal images are shown in fig. S2B. ( C ) Immunoblot from HEK293 cells expressing plasmids encoding intronic sense or antisense AAGGG/CCCTT repeat reporters in the +0/+1/+2 reading frames (left) and Nano-luciferase expression assay quantification (right). n = 7 biological replicates. Data were analyzed by one-way ANOVA with Sidak’s post hoc multiple comparison tests. ( D ) ICC of HEK293 cells transfected with plasmids encoding intronic sense or antisense AAGGG/CCCTT repeat reporters with C-terminal triple tags in the +0/+1/+2 reading frames. ( E ) Expression analysis of lysates from HEK293 cells transfected with control plasmid +2 Sense (AAGGG) 61 plasmid using anti-FLAG M2 (1:1000) and anti-KGREG (1:100) antibodies (left). ( F ) Left: IHC of control and RFC1 expansion CANVAS patient postmortem cerebellar vermis tissue stained with sense anti-KGREG antibody (1:100, acid AR). Scale bars, 500 μm (4×), 50 μm (60×), and 20 μm (inset). Right: Rater blinded quantification of all 20 postmortem tissues (tissue images and quantification for each sample in fig. S4). ( G ) Cumulative hazard plot for rat cortical neurons expressing CGG100 (positive control) or CANVAS intronic expression plasmids containing 61 repeats of the indicated type over 10 days. Results from eight technical replicates/three biological replicates; n = numbers of cells assessed per condition. ns, not significant. *hazard ratio = 1.339, P = 0.025, Cox proportional hazards analysis.

Journal: Science Advances

Article Title: AAGGG repeat expansions trigger RFC1 -independent synaptic dysregulation in human CANVAS neurons

doi: 10.1126/sciadv.adn2321

Figure Lengend Snippet: ( A ) Schematic of potential peptide products from sense and antisense strand of the repeat expansion locus. ( B ) Quantification of foci positive neurons for control ( n = 3) and CANVAS ( n = 3) patient iPSC-derived neurons (1100 to 2000 cells per group per probe). n = 2 biological replicates from three independent patient-derived cell lines. Representative confocal images are shown in fig. S2B. ( C ) Immunoblot from HEK293 cells expressing plasmids encoding intronic sense or antisense AAGGG/CCCTT repeat reporters in the +0/+1/+2 reading frames (left) and Nano-luciferase expression assay quantification (right). n = 7 biological replicates. Data were analyzed by one-way ANOVA with Sidak’s post hoc multiple comparison tests. ( D ) ICC of HEK293 cells transfected with plasmids encoding intronic sense or antisense AAGGG/CCCTT repeat reporters with C-terminal triple tags in the +0/+1/+2 reading frames. ( E ) Expression analysis of lysates from HEK293 cells transfected with control plasmid +2 Sense (AAGGG) 61 plasmid using anti-FLAG M2 (1:1000) and anti-KGREG (1:100) antibodies (left). ( F ) Left: IHC of control and RFC1 expansion CANVAS patient postmortem cerebellar vermis tissue stained with sense anti-KGREG antibody (1:100, acid AR). Scale bars, 500 μm (4×), 50 μm (60×), and 20 μm (inset). Right: Rater blinded quantification of all 20 postmortem tissues (tissue images and quantification for each sample in fig. S4). ( G ) Cumulative hazard plot for rat cortical neurons expressing CGG100 (positive control) or CANVAS intronic expression plasmids containing 61 repeats of the indicated type over 10 days. Results from eight technical replicates/three biological replicates; n = numbers of cells assessed per condition. ns, not significant. *hazard ratio = 1.339, P = 0.025, Cox proportional hazards analysis.

Article Snippet: CANVAS and control postmortem brain tissue was obtained with informed consent of the patients or their relatives and the approval of the local IRBs from the University of Michigan Brain Bank (IRB: HUM00041576), Mass General Brigham Stem Cells in Neurodegeneration Center (IRB: 2020P002649), UCL Queen Square Brain Bank for Neurological Disorders (REC: 08/H0718/54+5), and The Netherlands Brain Bank (IRB: IRB00002991).

Techniques: Control, Derivative Assay, Western Blot, Expressing, Luciferase, Comparison, Transfection, Plasmid Preparation, Staining, Positive Control

( A ) Endpoint RT-PCR utilizing primer sets spanning RFC1 exon 2–exon 3 or exon 2–intron 2 in CANVAS fibroblasts (top, left), iPSC-derived neurons (top, right), and CANVAS postmortem brain (bottom, left). ( B ) Quantification of normalized circular back-spliced read counts for RFC1 and other known circRNA species in CANVAS patient iPSC–derived neurons by paired-end RNA-seq analysis. ( C ) Ten-day time-course analysis of the rate of cellular division and proliferation in CANVAS ( n = 4) and control ( n = 3) fibroblast lines (left, F 6,287 = 8.54, P < 0.0001), CANVAS ( n = 3) and control ( n = 3) NPC lines (center, F 5,240 = 12.88, P < 0.0001), and CANVAS fibroblast lines ( n = 3) mock-treated or treated with RFC1 overexpression lentivirus (right, F 5,240 = 2.358, P = 0.245). n = 3 biological replicates from three to four independent patient cell lines. Data were analyzed by one-way ANOVA with Sidak’s post hoc multiple comparison tests. ( D and E ) Analysis of recovery after discrete UV exposure and DNA damage in CANVAS patient iPSC–derived neurons. (D) Representative images of γ-H2AX staining of iPSC-derived neurons before and after 60 mJ/cm 2 UV exposure (scale bar, 10 μm). (E) Quantification of mean γ-H2AX staining in CANVAS patient ( n = 3) and control ( n = 3) iPSC–derived NeuN+ neuronal nuclei over a 24-hour period after 60 mJ/cm 2 UV exposure ( n = 16,569 NeuN+ nuclei total). Data were analyzed by one-way ANOVA with post hoc multiple comparison tests. ( F ) First-derivative DNA damage recovery rate curves for CANVAS ( n = 3) and control ( n = 3) patient iPSC–derived neurons. Error = SD.

Journal: Science Advances

Article Title: AAGGG repeat expansions trigger RFC1 -independent synaptic dysregulation in human CANVAS neurons

doi: 10.1126/sciadv.adn2321

Figure Lengend Snippet: ( A ) Endpoint RT-PCR utilizing primer sets spanning RFC1 exon 2–exon 3 or exon 2–intron 2 in CANVAS fibroblasts (top, left), iPSC-derived neurons (top, right), and CANVAS postmortem brain (bottom, left). ( B ) Quantification of normalized circular back-spliced read counts for RFC1 and other known circRNA species in CANVAS patient iPSC–derived neurons by paired-end RNA-seq analysis. ( C ) Ten-day time-course analysis of the rate of cellular division and proliferation in CANVAS ( n = 4) and control ( n = 3) fibroblast lines (left, F 6,287 = 8.54, P < 0.0001), CANVAS ( n = 3) and control ( n = 3) NPC lines (center, F 5,240 = 12.88, P < 0.0001), and CANVAS fibroblast lines ( n = 3) mock-treated or treated with RFC1 overexpression lentivirus (right, F 5,240 = 2.358, P = 0.245). n = 3 biological replicates from three to four independent patient cell lines. Data were analyzed by one-way ANOVA with Sidak’s post hoc multiple comparison tests. ( D and E ) Analysis of recovery after discrete UV exposure and DNA damage in CANVAS patient iPSC–derived neurons. (D) Representative images of γ-H2AX staining of iPSC-derived neurons before and after 60 mJ/cm 2 UV exposure (scale bar, 10 μm). (E) Quantification of mean γ-H2AX staining in CANVAS patient ( n = 3) and control ( n = 3) iPSC–derived NeuN+ neuronal nuclei over a 24-hour period after 60 mJ/cm 2 UV exposure ( n = 16,569 NeuN+ nuclei total). Data were analyzed by one-way ANOVA with post hoc multiple comparison tests. ( F ) First-derivative DNA damage recovery rate curves for CANVAS ( n = 3) and control ( n = 3) patient iPSC–derived neurons. Error = SD.

Article Snippet: CANVAS and control postmortem brain tissue was obtained with informed consent of the patients or their relatives and the approval of the local IRBs from the University of Michigan Brain Bank (IRB: HUM00041576), Mass General Brigham Stem Cells in Neurodegeneration Center (IRB: 2020P002649), UCL Queen Square Brain Bank for Neurological Disorders (REC: 08/H0718/54+5), and The Netherlands Brain Bank (IRB: IRB00002991).

Techniques: Reverse Transcription Polymerase Chain Reaction, Derivative Assay, RNA Sequencing, Control, Over Expression, Comparison, Staining

(A and B) Immunohistochemistry of VCP and SOD1 in postmortem motor (affected) (A) and occipital (unaffected) (B) cortex from an ALS patient (patient #1-JHU74) carrying the A4V mutation in the SOD1 gene. The pictures on the right column represent the magnified regions within the yellow dashed squares. Scale bar, 20 μm. (C) Quantification of SOD1 and VCP intensities in MAP2 + neurons within the motor or occipital cortex. Motor cortex, n = 17 neurons; occipital cortex, n = 16 neurons. Unpaired t test (two-tailed), SOD1 p < 0.0001; VCP p < 0.0001.

Journal: Cell reports

Article Title: Analysis of proteome-wide degradation dynamics in ALS SOD1 iPSC-derived patient neurons reveals disrupted VCP homeostasis

doi: 10.1016/j.celrep.2023.113160

Figure Lengend Snippet: (A and B) Immunohistochemistry of VCP and SOD1 in postmortem motor (affected) (A) and occipital (unaffected) (B) cortex from an ALS patient (patient #1-JHU74) carrying the A4V mutation in the SOD1 gene. The pictures on the right column represent the magnified regions within the yellow dashed squares. Scale bar, 20 μm. (C) Quantification of SOD1 and VCP intensities in MAP2 + neurons within the motor or occipital cortex. Motor cortex, n = 17 neurons; occipital cortex, n = 16 neurons. Unpaired t test (two-tailed), SOD1 p < 0.0001; VCP p < 0.0001.

Article Snippet: Patient 1 (JHU74), postmortem ALS brain tissue from motor and occipital cortex , Johns Hopkins University , SOD1 +/A4V , Male,47 (age of death).

Techniques: Immunohistochemistry, Mutagenesis, Two Tailed Test

Journal: Cell reports

Article Title: Analysis of proteome-wide degradation dynamics in ALS SOD1 iPSC-derived patient neurons reveals disrupted VCP homeostasis

doi: 10.1016/j.celrep.2023.113160

Figure Lengend Snippet:

Article Snippet: Patient 1 (JHU74), postmortem ALS brain tissue from motor and occipital cortex , Johns Hopkins University , SOD1 +/A4V , Male,47 (age of death).

Techniques: Cell Culture, Sterility, Recombinant, Multiplex sample analysis, Western Blot, Stripping, Protease Inhibitor, Plasmid Preparation, Activity Assay, Magnetic Beads, Ligation, Bicinchoninic Acid Protein Assay, Mass Spectrometry, Virus, Software